Cycs is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Cytochrome c | |
|---|---|
| Gene Symbol | CYCS |
| Full Name | Cytochrome c |
| Chromosome | 7p15.3 |
| NCBI Gene ID | 54205 |
| OMIM | 123970 |
| Ensembl ID | ENSG00000172115 |
| UniProt ID | P99999 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Stroke, Cancer |
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
Cytochrome c (CYCS) is a small heme protein located in the mitochondrial intermembrane space that plays a central role in both cellular respiration and apoptosis. In the electron transport chain, cytochrome c functions as an electron carrier between Complex III and Complex IV. During apoptosis, cytochrome c is released from mitochondria into the cytosol following mitochondrial outer membrane permeabilization (MOMP), where it binds to APAF1 and facilitates apoptosome formation.
The release of cytochrome c is a critical step in the intrinsic (mitochondrial) apoptosis pathway. Once in the cytosol, cytochrome c binds to Apoptotic Protease Activating Factor 1 (APAF1) in a dATP/ATP-dependent manner, triggering oligomerization of the APAF1-cytochrome c complex to form the apoptosome. This heptameric complex recruits and activates procaspase-9, initiating the caspase cascade that leads to programmed cell death.
Cytochrome c is ubiquitously expressed in all aerobic cells, with highest levels in tissues with high metabolic rates including brain, heart, liver, and kidney. In neurons, cytochrome c is essential for mitochondrial function and neuronal survival. Its release is tightly regulated by anti-apoptotic BCL2 family proteins.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Alzheimer's Disease | Altered release | Acquired | Excessive cytochrome c release triggers neuronal apoptosis |
| Parkinson's Disease | Altered release | Acquired | Dopaminergic neuron vulnerability to cytochrome c-mediated apoptosis |
| Stroke/Ischemia | Release increased | Acquired | Excitotoxic injury triggers mitochondrial cytochrome c release |
| Cancer | Dysregulated | Somatic | Alterations in cytochrome c release affect apoptosis sensitivity |
The study of Cycs has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.